mRNA-based cancer therapeutics.

Liu, Chuang; Shi, Qiangqiang; Huang, Xiangang; Koo, Seyoung; Kong, Na; Tao, Wei

Liu, Chuang; Shi, Qiangqiang; Huang, Xiangang; Koo, Seyoung; Kong, Na; Tao, Wei.

Afiliação

Liu C; Center for Nanomedicine and Department of Anaesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Shi Q; Center for Nanomedicine and Department of Anaesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Huang X; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
Koo S; Center for Nanomedicine and Department of Anaesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Kong N; Center for Nanomedicine and Department of Anaesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tao W; Center for Nanomedicine and Department of Anaesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. kongna@zju.edu.cn.

Nat Rev Cancer ; 23(8): 526-543, 2023 08.

Article em En | MEDLINE | ID: mdl-37311817

Assuntos

Neoplasias; Receptores de Antígenos Quiméricos; Humanos; RNA Mensageiro/genética; RNA Mensageiro/metabolismo; Imunoterapia; Neoplasias/genética; Neoplasias/terapia; Citocinas

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Revista: Nat Rev Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google